Clinical Trial

Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome

Study acronym: SLIM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 5, 2021 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-07-10; most recent amendment 2021-10-04.
Trial Details
NCT Number NCT03584204
Lead Sponsor University Hospital, Bonn
Collaborators: University of Roma La Sapienza
Conditions Liver Cirrhosis
Enrollment 400 participants
Start Date 2018-01-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2021-10-05